Several tumor types express the gastrin gene (with the exception of neuroendocrine tumors); however, post-translational processing in these cells generally stops short of generating amidated gastrins, and the main products (progastrin and G17 or G34 extended by C-terminal Gly) are not thought to be physiological ligands for CCK2R. This evidence concerns the gene GAST and neoplasm.